Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability

por Hopkins, Ashley M., Rowland, Andrew, Sorich, Michael J.
Publicado 2018

Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing

por Ruanglertboon, Warit, Sorich, Michael J., Hopkins, Ashley M., Rowland, Andrew
Publicado 2021

Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift

por Hopkins, Ashley M, Logan, Jessica M, Kichenadasse, Ganessan, Sorich, Michael J
Publicado 2023

Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel

por Hopkins, Ashley M., Rowland, Andrew, McKinnon, Ross A., Sorich, Michael J.
Publicado 2019

Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab

por Hopkins, Ashley M, Kichenadasse, Ganessan, Karapetis, Chris S, Rowland, Andrew, Sorich, Michael J
Publicado 2020

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials

por Hopkins, Ashley M., Nguyen, Anh-Minh, Karapetis, Christos S., Rowland, Andrew, Sorich, Michael J.
Publicado 2018

Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials

por Hopkins, Ashley M., Rathod, Akash D., Rowland, Andrew, Kichenadasse, Ganessan, Sorich, Michael J.
Publicado 2020

Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data

por Hopkins, Ashley M., Shahnam, Adel, Zhang, Sasha, Karapetis, Chris S., Rowland, Andrew, Sorich, Michael J.
Publicado 2019

Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events

por Logan, Jessica M., Brooks, Doug A., Rowland, Andrew, Sorich, Michael J., Hopkins, Ashley M.
Publicado 2021

Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised C...

por Manning-Bennett, Arkady T, Cervesi, Julie, Bandinelli, Pierre-Alain, Sorich, Michael J, Hopkins, Ashley M
Publicado 2023

Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease

por Newman, Lauren A., Useckaite, Zivile, Johnson, Jillian, Sorich, Michael J., Hopkins, Ashley M., Rowland, Andrew
Publicado 2022

Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials

por Li, Lee X, Cappuzzo, Federico, Matos, Ignacio, Socinski, Mark A, Hopkins, Ashley M, Sorich, Michael J
Publicado 2023

Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy

por Booth, Andrew E. C., Hopkins, Ashley M., Rowland, Andrew, Kichenadasse, Ganessan, Smith, Justine R., Sorich, Michael J.
Publicado 2020

Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Tr...

por Hopkins, Ashley M., Kichenadasse, Ganessan, Abuhelwa, Ahmad Y., McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J.
Publicado 2021

Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer

por Abuhelwa, Ahmad Y., Kichenadasse, Ganessan, McKinnon, Ross A., Rowland, Andrew, Hopkins, Ashley M., Sorich, Michael J.
Publicado 2021

Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combinati...

por Hopkins, Ashley M., Kichenadasse, Ganessan, Abuhelwa, Ahmad Y., McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J.
Publicado 2021

The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy

por Badaoui, Sarah, Shahnam, Adel, McKinnon, Ross A., Abuhelwa, Ahmad Y., Sorich, Michael J., Hopkins, Ashley M.
Publicado 2022

Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs

por Abuhelwa, Ahmad Y., Hopkins, Ashley M., Sorich, Michael J., Proudman, Susanna, Foster, David J. R., Wiese, Michael D.
Publicado 2020

Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Su...

por van Dyk, Madelé, Kapetas, Asha J., Hopkins, Ashley M., Rodrigues, A. David, Vourvahis, Manoli, Sorich, Michael J., Rowland, Andrew
Publicado 2019

Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine

por Ang, Fang L.I., Rowland, Andrew, Modi, Natansh D., McKinnon, Ross A., Sorich, Michael J., Hopkins, Ashley M.
Publicado 2020